Scinai Immunotherapeutics Ltd. American Depositary Shares

SCNIRank #124
$1.23−21.15% 1D
$1.1352-week range$16.30

Updated . Prices are snapshots and may be delayed.

Scinai Immunotherapeutics Ltd. American Depositary Shares price chart

−17.70% over 7D
$1.40
$0.84
Oct 19
Oct 20

AI Outlook for Scinai Immunotherapeutics Ltd. American Depositary Shares

Bearish posture
  • Long-term trend
    -81.7% vs 200-day average
  • Medium-term trend
    -54.9% vs 50-day average
  • Averages
    50-day below 200-day
  • 3 more trend and momentum checks
  • Nearby support and resistance levels
  • What would strengthen or weaken the picture

Posture describes where the price stands today, from its own trend and momentum. It is not a forecast, a price target or financial advice. How it is worked out

Scinai Immunotherapeutics Ltd. American Depositary Shares performance

1D
−21.2%
7D
+0.8%
30D
−25.9%
90D
−53.2%
1Y
−91.2%

About Scinai Immunotherapeutics Ltd. American Depositary Shares

Scinai Immunotherapeutics Ltd. American Depositary Shares is a biotechnology company (ticker SCNI).

Its market capitalisation is $1 million, the #124 largest of the 126 stocks Air Radar has market-cap data for.

Scinai Immunotherapeutics Ltd. American Depositary Shares market data

What is the price of Scinai Immunotherapeutics Ltd. American Depositary Shares today?

Scinai Immunotherapeutics Ltd. American Depositary Shares (SCNI) is at $1.23, −21.15% on the day.

What is the 52-week range of Scinai Immunotherapeutics Ltd. American Depositary Shares?

Over the past year Scinai Immunotherapeutics Ltd. American Depositary Shares has traded between $1.13 and $16.30. It is currently 1% of the way up that range.

What is the market cap of Scinai Immunotherapeutics Ltd. American Depositary Shares?

Scinai Immunotherapeutics Ltd. American Depositary Shares has a market capitalisation of $785,994, the #124 largest of the stocks Air Radar has market-cap data for.

Similar stocks

Prices are snapshots from market data providers and may be delayed. This page is for information only and is not investment advice.